These findings suggest that SARS-CoV-2 can induce aberrant and ectopic expression of ERVW-1, which can contribute to the immunopathology of COVID-19 such as dysregulation of innate immunity associated with hyper-inflammation [73]. This evidence concerns the gene ERVW-1 and COVID-19.